Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04589338
Other study ID # 20202021
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 5, 2021
Est. completion date February 7, 2023

Study information

Verified date May 2023
Source University of Liege
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective interventional study. The investigators will include patients in clinical remission who are on stable treatment. These IBD patients will be followed to analyze the effects of physical activity on their inflammatory disease. Different exercises will be offered to two separate groups of randomly distributed patients: the first group will perform muscle building exercises while the other group will be offered aerobic exercises.There will also be a control group that does not initially benefit from a specific physical activity program. However, this group will be integrated into one of the other two groups after the 10-week follow-up. All three groups will perform the same baseline tests. These will be of different types: physical tests, biological tests and quality of life questionnaires.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date February 7, 2023
Est. primary completion date December 15, 2022
Accepts healthy volunteers No
Gender All
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria: - Patients in remission defined by a Harvey Bradshaw Index 5 in Crohn's disease (CD) and a clinical Mayo 3 with no sub-score >1 in ulcerative colitis (RCUH) with stable treatment, without corticosteroid for 4 months. - Patients accepting the study protocol Exclusion Criteria: - Patients suffering from other pathologies (at the level of the digestive system, the cardiovascular system, as well as the musculoskeletal system: recent knee plasty, recent knee fractures, etc.), which can interfere with planned tests and activity programs. - Patients with more than 3 hours of sports activity per week - Pregnant, pregnant or nursing patients

Study Design


Intervention

Other:
Endurance training
This group will perform aerobic type exercises. Initially, patients will perform continuous exercises of progressive intensity in order to adapt to this kind of effort. Next, we will introduce interval exercises.
Resistance training
Patients in this group will perform lower limb strengthening exercises to improve the maximum strength of different muscle groups.

Locations

Country Name City State
Belgium Université de Liège Liège

Sponsors (1)

Lead Sponsor Collaborator
University of Liege

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Progressive effort test on bicycle ergometer (VO2 max) This test allows to measure VO2 in ml/min/kg (thanks to respiratory gases) day 1
Primary Progressive effort test on bicycle ergometer (VO2 max) This test allows to measure VO2 in ml/min/kg (thanks to respiratory gases) through study completion, an average of 40 weeks
Primary Progressive effort test on bicycle ergometer (Heart rate) This test allows to measure resting and maximum heart rate (thanks to an ECG) and maximum aerobic power in Watt. day 1
Primary Progressive effort test on bicycle ergometer (Heart rate) This test allows to measure resting and maximum heart rate (thanks to an ECG) and maximum aerobic power in Watt. through study completion, an average of 40 weeks
Primary Progressive effort test on bicycle ergometer (Power) This test allows to measure maximum aerobic power in Watt. day 1
Primary Progressive effort test on bicycle ergometer (Power) This test allows to measure maximum aerobic power in Watt. through study completion, an average of 40 weeks
Primary Maximum force test (N/m) This test will be performed using an isokinetic dynamometer. This evaluation will allow us to determine the maximum force of the quadriceps and hamstrings of each participant in N/m. Day 1
Primary Maximum force test (N/m) This test will be performed using an isokinetic dynamometer. This evaluation will allow us to determine the maximum force of the quadriceps and hamstrings of each participant in N/m. through study completion, an average of 40 weeks
Primary Blood sample This type of tests includes biological monitoring to obtain information on biological parameters. Day 1
Primary Blood sample This type of tests includes biological monitoring to obtain information on biological parameters. through study completion, an average of 40 weeks
Primary Saddle analysis This type of tests includes biological monitoring to obtain information on biological parameters. Day 1
Primary Saddle analysis This type of tests includes biological monitoring to obtain information on biological parameters. through study completion, an average of 40 weeks
Primary IBD-F Participants will complete a questionnaire on fatigue perceived. Week 1
Primary IBD-F Participants will complete a questionnaire on fatigue perceived. Week 10
Primary IBD-F Participants will complete a questionnaire on fatigue perceived. Week 20
Primary Godin Leisure Time exercise questionnaire Participants will complete a questionnaire on the level of physical activity Week 1
Primary Metabolic Equivalent Task questionnaire Participants will complete a questionnaire on the level of inactivity Week 1
Primary Metabolic Equivalent Task questionnaire Participants will complete a questionnaire on the level of inactivity Week 10
Primary Metabolic Equivalent Task questionnaire Participants will complete a questionnaire on the level of inactivity Week 20
Primary Short Food Frequency Questionnaire Participants will complete a questionnaire on their dietary habits Week 1
Primary Short Food Frequency Questionnaire Participants will complete a questionnaire on their dietary habits Week 10
Primary Short Food Frequency Questionnaire Participants will complete a questionnaire on their dietary habits Week 20
Primary EQ5D questionnaire Participants will complete a questionnaire on their level of health Week 1
Primary EQ5D questionnaire Participants will complete a questionnaire on their level of health Week 10
Primary EQ5D questionnaire Participants will complete a questionnaire on their level of health Week 20
Primary Short health scale questionnaire Participants will complete a questionnaire to evaluate the level of the inflammatory bowel disease Week 1
Primary Short health scale questionnaire Participants will complete a questionnaire to evaluate the level of the inflammatory bowel disease Week 10
Primary Short health scale questionnaire Participants will complete a questionnaire to evaluate the level of the inflammatory bowel disease Week 20
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04046913 - The ADDapt Diet in Reducing Crohn's Disease Inflammation N/A
Active, not recruiting NCT04989907 - A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland
Recruiting NCT05316584 - A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy N/A
Active, not recruiting NCT04990258 - A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC
Completed NCT06216223 - Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients N/A
Enrolling by invitation NCT06015789 - Self-care in Patients Affected by Inflammatory Bowel Disease and Caregivers' Contribution to Self-care
Recruiting NCT06065995 - StoMakker Mobile Application N/A
Recruiting NCT03282786 - Comparison of Carbon Dioxide (CO2) to Air Insufflation in Colonoscopy in Patients With Inflammatory Bowel Disease N/A
Recruiting NCT06002074 - SMART Program Impact on Quality of Life in Inflammatory Bowel Diseases N/A
Recruiting NCT04960826 - Study of an Environmental Risk Factor in Crohn's Disease
Recruiting NCT05413941 - Internet-based Cognitive Behavioral Therapy in Inflammatory Bowel Disease N/A
Completed NCT03668249 - A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)
Completed NCT00721812 - A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686 Phase 1
Recruiting NCT05809999 - IBD Neoplasia Surveillance RCT N/A
Recruiting NCT04138225 - The Ecological Role of Yeasts in the Human Gut
Recruiting NCT04991324 - Cholecalciferol Comedication in IBD - the 5C-study Phase 3
Completed NCT03173144 - Chronic Inflammatory Disease, Lifestyle and Treatment Response
Not yet recruiting NCT05043818 - A Clinical Study on the Screening of Intestinal Biomarkers in IBD Patients With Depression
Recruiting NCT03042091 - Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery Early Phase 1
Completed NCT02874365 - Intestinal Stem Cells Characterization N/A